AzTrials
AzTrials

Postoperative DeliriumNCT05434455

Effect of RIPC on the Prevention of POD in Patients Undergoing Cardiac Surgery

A study testing RIPC induced with 3 cycles of 5 minutes of ischaemia and 5 minutes of reperfusion in people with Postoperative Delirium and Cardiac Surgery, run by Shanghai Zhongshan Hospital.

Unknown status

Status not confirmed. The sponsor has not verified this record for over two years, so it may be out of date.

Official record
Search all trials

Trial summary

Postoperative delirium (POD) is one of the most frequent neurological complications in elderly patients and is closely associated with longer ICU stay and hospitalization, deterioration of long-term neurocognitive function, and increased mortality. Read more about this study

Who is it for?
Ages 18 to 80 years
Conditions the study is for
Postoperative Delirium, Cardiac Surgery
What is being tested?
RIPC induced with 3 cycles of 5 minutes of ischaemia and 5 minutes of reperfusion
Type of treatment
Medical device
Could I receive a placebo?
No, everyone receives an active treatment
How many people
216 participants
Where
No sites listed yet
Study dates
1 Jul 2022to 31 Dec 2023
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 to 80 years
  • All sexes
  • No healthy volunteers
  • Adult, Older adult

Who may be able to join

  • patients undergoing elective cardiac surgery;
  • age ≥ 18 yr;
  • any sex;
  • American Society of Anesthesiologists (ASA) class ≥II class;
  • New York Heart Association (NYHA) ≥II class.

Who cannot join

  • emergency surgery;
  • a history of cardiovascular surgery;
  • peripheral vascular disease affecting the upper limbs;
  • acute myocardial infarction (MI) up to 14 days before surgery;
  • a history of severe injuries and operations within 3 months before cardiac surgery;
  • a history of cancer and chronic autoimmune diseases.

About this study

Official title: Effects of Remote Ischemic Preconditioning(RIPC) on the Prevention of Postoperative Delirium in Patients Undergoing Cardiac Surgery: A Pilot Randomized Clinical Trial

Postoperative delirium (POD) is one of the most frequent neurological complications in elderly patients and is closely associated with longer ICU stay and hospitalization, deterioration of long-term neurocognitive function, and increased mortality. The incidence of POD is significantly higher in elderly patients undergoing cardiac surgery than in other populations. Therefore, the prevention of POD is an important clinical problem to be solved urgently. In this study, we intend to observe the effect of RIPC on the prevention and treatment of POD in patients undergoing cardiac surgery through a prospective randomized controlled trial.

Being tested
RIPC induced with 3 cycles of 5 minutes of ischaemia and 5 minutes of reperfusion
Medical subject headings
Emergence Delirium

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • RIPC induced with 3 cycles of 5 minutes of ischaemia and 5 minutes of reperfusionDevice

    RIPC was induced with 3 cycles of 5 minutes of ischaemia and 5 minutes of reperfusion on the upper arm. By using blood pressure cuff inflation, patients in the RIPC group were exposed to a pressure 50 mmHg higher than the systolic radial artery pressure baseline.

Study groups in NCT05434455
Study groupRoleWhat they receive
RIPCExperimentalRIPC was induced with 3 cycles of 5 minutes of ischaemia and 5 minutes of reperfusion on the upper arm. By using blood pressure cuff inflation, patients in the RIPC group were exposed to a pressure 50 mmHg higher than the systolic radial artery pressure baseline.
Receives: Device: RIPC induced with 3 cycles of 5 minutes of ischaemia and 5 minutes of reperfusion
ConNo interventionThe control group had a deflated cuff placed on the upper arm for the same time.

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Incidence of postoperative delirium

    Patients were assessed for postoperative delirium by the Confusion Assessment Method (CAM) from the time they were transferred to the ICU at the end of surgery until 7 days postoperatively or before discharge, whichever came first

    Measured: 7 days postoperatively or before discharge, whichever came first

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted28 Jun 2022
  2. Study start1 Jul 2022 (estimated)
  3. Primary completion14 Jul 2022 (estimated)
  4. Study completion31 Dec 2023 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Prevention
Allocation
Randomised
Intervention model
Single group
Masking
Single blind
Who is masked
Participant
Enrolment
216 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT05434455
Sponsor's protocol ID
2022RIPC-delirium
Status last verified
Jun 2022
First submitted
22 Jun 2022
Last updated
30 Jun 2022
Results posted
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
Undecided

Questions about this trial

What is this clinical trial studying?

A study testing RIPC induced with 3 cycles of 5 minutes of ischaemia and 5 minutes of reperfusion in people with Postoperative Delirium and Cardiac Surgery, run by Shanghai Zhongshan Hospital.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 5 inclusion and 6 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: status not confirmed, as of the sponsor's last update on 30 Jun 2022. Status can change between updates, so confirm with the study contact before making plans.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

Results are not available in the source record.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Incidence of postoperative delirium (time frame: 7 days postoperatively or before discharge, whichever came first). It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 30 Jun 2022.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in